"Ascension St. John Medical Center in Tulsa, Oklahoma, is a full-service hospital with 24/7 emergency care, trauma center and stroke center. We deliver advanced surgical care for serious and life-threatening injuries and illnesses. Our care teams listen to quickly understand your health needs and deliver care that's right for you. Ascension St. John is a destination for specialty care - including cardiology, brain and spine care, kidney transplant, bariatric surgery, sleep disorders, wound care and diabetes education. Our OB-GYN, maternal-fetal care teams deliver a personalized birthing experience and advanced neonatal care. We offer a wide range of procedures, imaging, lab tests, respiratory care and rehabilitation therapies."

During the past decade, Ascension St. John conducted 7 clinical trials. In the 10-year time frame, 7 clinical trials started and 1 clinical trials were completed, i.e. on average, 14.3% percent of trials that started reached the finish line to date. In the past 5 years, 7 clinical trials started and 1 clinical trials were completed. i.e. 14.3% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Ascension St. John" #1 sponsor was "Pulmotect, Inc." with 2 trials, followed by "DiaMedica Therapeutics Inc" with 1 trials sponsored, "Genentech, Inc." with 1 trials sponsored, "Icahn School of Medicine at Mount Sinai" with 1 trials sponsored and "Mitsubishi Tanabe Pharma America Inc." with 1 trials sponsored. Other sponsors include -4 different institutions and companies that sponsored additional 6 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Ascension St. John" #1 collaborator was "United States Department of Defense" with 2 trials as a collaborator, "National Heart, Lung, and Blood Institute (NHLBI)" with 1 trials as a collaborator and "Vanderbilt University Medical Center" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were collaborators in the rest 3 trials.

According to Clinical.Site data, the most researched conditions in "Ascension St. John" are "COVID-19" (2 trials), "Stroke" (2 trials), "Acute Stroke" (1 trials), "Atrial Fibrillation" (1 trials) and "Bleeding" (1 trials). Many other conditions were trialed in "Ascension St. John" in a lesser frequency.

Most popular intervention types in "Ascension St. John" are "Drug" (5 trials), "Biological" (3 trials) and "Other" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (5 trials), "PUL-042 Inhalation Solution" (2 trials), "Antiplatelet-only strategy" (1 trials), "COVI-MSC" (1 trials) and "MT-3921" (1 trials). Other intervention names were less common.

The vast majority of trials in "Ascension St. John" are 7 trials for "All" genders.

Currently, there are NaN active trials in "Ascension St. John". undefined are not yet recruiting, 3 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 3 completed trials in Ascension St. John, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Ascension St. John, 0 "Phase 1" clinical trials were conducted, 5 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 0 trials that are defined as “Not Applicable".